These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study. Reinsch RC; Murphy AA; Morales AJ; Yen SS Am J Obstet Gynecol; 1994 Jun; 170(6):1623-7; discussion 1627-8. PubMed ID: 8203418 [TBL] [Abstract][Full Text] [Related]
6. Shrinkage effect of gonadotropin releasing hormone agonist treatment on uterine leiomyomas and t(12;14). Takahashi K; Kawamura N; Ishiko O; Ogita S Int J Oncol; 2002 Feb; 20(2):279-83. PubMed ID: 11788889 [TBL] [Abstract][Full Text] [Related]
7. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata. Schlaff WD; Zerhouni EA; Huth JA; Chen J; Damewood MD; Rock JA Obstet Gynecol; 1989 Dec; 74(6):856-62. PubMed ID: 2511532 [TBL] [Abstract][Full Text] [Related]
11. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial. Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549 [TBL] [Abstract][Full Text] [Related]
12. GnRH agonists before surgery for uterine leiomyomas. A review. Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917 [TBL] [Abstract][Full Text] [Related]
13. Myomectomy after selective preoperative treatment with a gonadotropin releasing hormone analog. Hutchins FL J Reprod Med; 1992 Aug; 37(8):699-702. PubMed ID: 1432986 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group]. Stolz W; Pfützenreuter N Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825 [TBL] [Abstract][Full Text] [Related]
15. [Usefulness of GnRH agonists in preoperative treatment of complicated uterine myomata]. Campusano C; Zapata R; Bianchi M; Badia JI; Arteaga E Rev Chil Obstet Ginecol; 1993; 58(2):150-4. PubMed ID: 8209044 [TBL] [Abstract][Full Text] [Related]
16. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas. Saltiel E Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243 [TBL] [Abstract][Full Text] [Related]
17. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Khan KN; Kitajima M; Hiraki K; Fujishita A; Sekine I; Ishimaru T; Masuzaki H Hum Reprod; 2010 Mar; 25(3):642-53. PubMed ID: 20008888 [TBL] [Abstract][Full Text] [Related]
18. [Short-term treatment with leuprolide acetate depot before surgical intervention for uterine leiomyomatosis]. D'Anna R; Palmara V; Lo Re C; Scilipoti A; Leonardi I Minerva Ginecol; 1994 Jun; 46(6):343-6. PubMed ID: 7936386 [TBL] [Abstract][Full Text] [Related]
19. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas. Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890 [TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist. Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]